홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Deoxycholic Acid

HCID 222528
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
83-44-3
표준 SMILES
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
InChIKey
KXGVEGMKQFWNSR-LLQZFEROSA-N
분자식
C24H40O4
평균 분자량
392.6 g/mol
단동위원소 질량
392.29265975

개요

Deoxycholic acid is a bile acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 12 respectively. It has a role as a human blood serum metabolite. It is a C24-steroid, a dihydroxy-5beta-cholanic acid and a bile acid. It is a conjugate acid of a deoxycholate.

이름 및 식별자

우선 이름
Deoxycholic Acid
IUPAC
(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
영어명
Deoxycholic acid
분자식
C24H40O4
분자량
392.58

이름 및 동의어

DEOXYCHOLIC ACID83-44-3CholerebicCholorebicCholeic acidDroxolanDegalolDesoxycholsaeureDeoxycholatic acidPyrocholSeptochol7-Deoxycholic acid
이름 더 보기
DEOXYCHOLATEdeoxycholicDESOXYCHOLIC ACID(R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-diMethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acidCHOLAIC ACIDDEOXYCHOLIC ACID FREE ACID SIGMAULTRANSC 8797
7alpha-Deoxycholic acid3alpha,12alpha-Dihydroxy-5beta-cholanic acidCholic acid, deoxy-3,12-Dihydroxycholanic acidATX-101Dihydroxycholanoic acidDeoxy cholic acid3alpha,12alpha-Dihydroxy-5beta-cholan-24-oic acid

데이터베이스 식별자

CAS
83-44-3
PubChem CID
222528
DTXSID
DTXSID0042662
ChEMBL

물성

구조 계산 물성

XLogP
4.9
극성 표면적
77.8 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
4
회전 가능 결합 수
4
무거운 원자 수
28
형식 전하
0
복잡도
605

실험 및 물리화학적 성질

Chemical Classes · 2건

Bile Acids -> Quant Bile Acids

Other Classes -> Organic Acids

DrugsPharmaceuticals -> Listed in ZINC15
LipidsLipids -> Sterol Lipids [ST] -> Bile acids and derivatives [ST04] -> C24 bile acids, alcohols, and derivatives [ST0401]
SpringerMaterials PropertiesCrystal structure
LogP · 2건

log Kow = 3.50

3.50

Color/FormCRYSTALS FROM ALC
Solubility · 4건

SOLUBILITY IN WATER: GREATER THAN 333 G/L @ 15 °C /NA SALT/

@ 15 °C: 0.24 G/L IN WATER, 220.7 G/L IN ALC, IN ETHER: 1.16 G/L, IN CHLOROFORM: 2.94 G/L, IN BENZENE: 0.12 G/L, IN ACETONE: 10.46 G/L, IN GLACIAL ACETIC ACID: 9.06 G/L; SOL IN SOLN OF ALKALI HYDROXIDES OR CARBONATES

water solubility = 43.6 mg/l @ 20 °C

0.0436 mg/mL

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Decomposition

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 49 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 3건

Chemical: Cholan-24-oic acid, 3,12-dihydroxy-, (3.alpha.,5.beta.,12.alpha.)-

REACH registered substance: 3-α,12-α-dihydroxy-5-β-cholan-24-oic acid (EC: 201-478-5)

Deoxycholic acid: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Cholan-24-oic acid, 3,12-dihydroxy-, (3.alpha.,5.beta.,12.alpha.)-: Human health tier I assessment
Hazards SummaryEmergency treatment: symptomatic drug ingestion; [HSDB] An irritant; [MSDSonline]
Hazard Classes and CategoriesAcute Tox. 4 (100%)

안전 및 보호

Disposal Methods · 1건

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

화학 및 산업

약리 정보

ATC Code · 2건

D - Dermatologicals

QD - Dermatologicals

Bionecessity · 1건

Normal functioning of the GI tract depends on appropriate synthesis and enterohepatic circulation of bile acids ... which are synthesized from cholesterol The primary bile acids are cholic acid and chenodeoxycholic acid. Bacterial metabolism of these primary bile acids in the colon forms secondary bile acids, of which deoxycholic acid is the principal specie. Secondary bile acids are absorbed in the colon and cycle with the primary bile acids. Cholic acid, chenodeoxycholic acid, and deoxy- cholic acid constitute 95% of the biliary bile acids.

Protein Binding98%
Mechanism of Action · 3건

As a bile acid, deoxycholic acid emulsifies fat in the gut. Synthetically derived deoxycholic acid, when injected, stimulates a targeted breakdown of adipose cells by disrupting the cell membrane and causing adipocytolysis. This results in an inflammatory reaction and clearing of the adipose tissue remnants by macrophages. Deoxycholic acid's actions are reduced by albumin and tissue-associated proteins, therefore its effect is limited to protein-poor subcutaneous fat tissue. Protein-rich tissues like muscle and skin are unaffected by deoxycholic acid, contributing to its safety profile.

IN SOLN CONJUGATED BILE SALTS FORM MICELLES IN WHICH LIPID MATERIALS MAY BE ENTRAINED. ...ALSO PROMOTE DIGESTION OF FATS BY STIMULATING PANCREATIC SECRETION & BY ACTIVATING PANCREATIC LIPASE. ... DEOXYCHOLIC.../ACID/ PROMOTE/S/ NET EXCRETION OF NA, K, & WATER IN COLON...MAY BE...FACTORS REGULATING COLONIC ABSORPTION.

DEOXYCHOLATE ADMIN DECR ABSORPTION OF CHOLESTEROL FROM HUMAN INTESTINAL TRACT. IT APPEARED TO INFLUENCE INTESTINAL FLORA AS ASSESSED INDIRECTLY BY ANALYSIS OF TYPES OF NEUTRAL STEROLS ELIM WITH FECES.

Metabolism/MetabolitesDeoxycholic acid is not metabolized to any significant extent under normal conditions.
FDA Pharmacological Classification · 6건

005990WHZZ

DEOXYCHOLIC ACID

관련 반응

18건
반응 기록 만들기
HRID 241529 반응식
HRID 241529반응물로
HRID 258235 반응식
HRID 258235반응물로
HRID 385172 반응식
HRID 385172생성물로
HRID 463532 반응식
HRID 463532반응물로
HRID 481936 반응식
HRID 481936생성물로
HRID 586111 반응식
HRID 586111반응물로
HRID 601753 반응식
HRID 601753생성물로
HRID 1296194 반응식
HRID 1296194생성물로
이전1 / 3 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
CHEMBL406393、CHEMBL453873
ChEBI
CHEBI:28834
UNII
005990WHZZ
EC Number
201-478-5
Nikkaji
J3.873C
When heated to decomposition it emits acrid smoke and irritating fumes.
Melting Point · 2건

176-178 °C

171 - 174 °C

Optical RotationSPECIFIC OPTICAL ROTATION: +55 DEG (ALCOHOL) @ 20 °C/D
Physical Description · 2건

Solid; [Merck Index] White powder; [MSDSonline]

Solid

물리화학적 성질

녹는점
171 · 171-174 °C(lit.)
끓는 점
437.26 °C · 437.26°C (rough estimate)
밀도
0.9985 · 0.9985 (rough estimate)
증기압
0.004 Pa · 0.004Pa at 20℃
굴절률
1.446 · 1.4460 (estimate)
인화점
9 ℃ · 9℃
저장 조건
room temp
용해도
0.24 g/L · 0.24g/L(15°C)
산도 계수 (pKa)
5.15 · 5.15(at 20℃)
물리적 상태
고체
색상
흰색에서 황백색까지
생물학적 소스
ox bile
수용성
0.24 g/L · 0.24g/L(15℃)
Merck
14 · 14,2899
BRN
3219882 · 3219882
안정성
안정적인. 타기 쉬운. 강한 산화제와 호환되지 않습니다.
화장품 원료 기능
피부 컨디셔닝보습제피부 컨디셔닝 - 보습제
InChIKey
KXGVEGMKQFWNSR-LLQZFEROSA-N
SMILES
C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
LogP
5.34 at · 5.34 at 22℃ and pH5.7
표면장력
54 mN/m · 54mN/m at 51.3mg/L and 20℃
EPA
-24 · Cholan-24-oic acid, 3,12-dihydroxy-, (3.alpha.,5.beta.,12.alpha.)- (83-44-3)

화학적 성질

white powder

독성 정보

Interactions · 3건

...COMPETITION FOR EXTRAVASCULAR BINDING SITES BY DEOXYCHOLIC ACID MAY EXPLAIN REDUCED VOL OF DISTRIBUTION OF BROMSULFOPHTHALEIN IN PRESENCE OF BILE ACID.

COMPD INCL DEOXYCHOLATE POTENTIATED ANTISTAPHYLOCOCCI ACTIVITY OF GENTAMYCIN, MONOMYCIN, KANAMYCIN, & NEOMYCIN.

Deoxycholic acid was tested alone and as a promoter of N-nitrosobis(2-hydroxypropyl)amine induced carcinogenesis in the hamster. Three groups of 5 to 6-wk-old male Syrian hamsters (SYR)/NI were used and 10 animals per group were given subcutaneous injections of 0.9% NaCl, once per week for 5 weeks. Group 1 received no further treatment; groups 2 and 3 received 0.1% and 0.5% DCA in their feed for 30 weeks, respectively. Animals were autopsied at week 35. There was no significant difference in body wt. between groups 1 and 2, whereas there was a significant decrease in body weight for group 3 (P<0.005). There were no liver tumors, bile duct proliferation, gallbladder lesions or polyps, pancreatic lesions, or pancreatic duct hyperplasia in these 3 groups. In the promoter study, three groups of 5 to 6-wk-old hamsters (number not stated) were given a subcutaneous injection of 500 mg/kg body wt. N-nitrosobis(2-hydroxypropyl)amine per week for 5 weeks. Group 4 received no further treatment and the N-nitrosobis(2-hydroxypropyl)amine treatment was followed by 0.1% DCA (group 5) , or 0.5% DCA (group 6) in the feed for 30 weeks. There was a significant body weight loss (P<0.005) for groups 5 and 6 compared to group 4. DCA significantly increased the induction of cholangiocarcinomas 10/19 in group 5 (P<0.006); 9/25 in group 6 (P<0.05) compared to group 4 which had 1/15. Pancreatic carcinomas were significantly increased in group 5 (14/19, P<0.03). Therefore, under the conditions of this experiment, DCA was not carcinogenic when given alone but was an effective promoter of N-nitrosobis(2-hydroxypropyl)amine-induced hepatic and pancreatic carcinogenesis in hamsters.

Health EffectsChronically high levels of deoxycholic acid are associated with several forms of cancer including colon cancer.
Natural Pollution Sources · 2건

DEOXYCHOLIC /ACID IS/...FORMED IN INTESTINE BY ACTION OF /ENTERIC/ BACTERIA ON SECRETED BILE ACIDS.

OCCURS IN BILE OF MAN, OX, SHEEP, DOG, GOAT & RABBIT.

Human Toxicity Excerpts · 2건

Excess bile acids reaching the colon can reduce net water absorption and cause diarrhea. /Bile acids/

FOLLOWING IV INJECTION OF BILE SALTS...THERE IS MARKED FALL IN BLOOD PRESSURE ACCOMPANIED BY A BRADYCARDIA. ...JAUNDICE... IV, BILE SALTS CAUSE SKELETAL MUSCULAR HYPERACTIVITY, TWITCHING, SPASM, DECR IN THRESHOLD FOR NERVE IMPULSES. ...BILE ACIDS...CAUSE LYSIS OF RED & WHITE BLOOD CELLS. /BILE SALTS & BILE ACIDS/

Carcinogen ClassificationNot listed by IARC.
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Deoxycholic acid

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Non-Human Toxicity Excerpts · 5건

IN DOGS, BILE SALTS DAMAGE GASTRIC MUCOSAL BARRIER, WHICH RESULTS IN BACK DIFFUSION OF ACID. ALTHOUGH NET DIFFUSION INTO LUMEN IS DIMINISHED, MUCOSAL CONCN IS INCREASED & ULCERATION OCCURS. /BILE SALTS/

DEOXYCHOLIC ACID ADDED TO CULTURES: WAS HIGHLY TOXIC TO RAT FIBROBLASTS & COLON CANCER CELLS, LESS TOXIC TO LIVER EPITHELIAL CELLS.

3 MMOL/L INSTILLED INTO RAT COLON LUMEN INCR PERMEABILITY TO WATER & TO UREA, MANNITOL & LACTOSE; DID NOT AFFECT OSMOTIC FILTRATION COEFFICIENTS.

CHOLIC ACID, TAUROCHOLIC ACID, GLYCOCHOLIC ACID, & DEOXYCHOLIC ACID EXERTED ANTIMICROBIAL ACTIVITY AGAINST STAPH IN VITRO: DEOXYCHOLATE MOST EFFECTIVE.

Although hepatocarcinogenesis has been reported to be promoted by exogenous administration of bile acids, the relation of endogenous bile acids to hepatocarcinogenesis is not completely understood. This study investigates the relationship between serum concentration of bile acids, the appearance of preneoplastic change, glutathione S-transferase placental form positive foci in the liver of male Donryu rats which had been fed 0.06% 3'-methyl-4-dimethylamino-azobenzene, and the effects of gomisin A, previously reported to inhibit the tumor promotion process. During the feeding of 3'-methyl-4-dimethylamino-azobenzene for 5 wks, the concn of serum bile acids were found to have increased significantly to several times the levels found at the start of the experiment. The increase of serum bile acids, especially deoxycholic acid, and the appearance of preneoplastic lesions, the number and area of glutathione S-transferase placental-positive foci in the liver, were significantly inhibited by simultaneous oral administration of gomisin A (30 mg/kg). When deoxycholic acid (100 mg/kg) was orally administered after an initiation by 3'-methyl-4-dimethylamino-azobenzene, serum bile acids and preneoplastic changes were significantly increased, these increases were inhibited by combined feeding of 0.03% gomisin A in the diet. There were good correlations between the serum concn of deoxycholic acid and the number of glutathione S-transferase placental-positive foci in the liver in both experimental protocols. These results confirm that deoxycholic acid is an endogenous risk factor for hepatocarcinogenesis and suggest that anti-promoter effect of gomisin A is based on improving metabolism of bile acids, including deoxycholic acid.

안전 데이터

wgk
3
tsca
TSCA listed
rtecs
FZ2100000
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
독성
LD50 oral in rat: 1gm/kg
HS 번호
29181990
risk_code
22-36/37/38-37-20/21/22
hazard_code
Xn
safety_code
26-36-37/39-22
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
스토리지 클래스
3 - Flammable liquids
유해 물질 데이터
83-44-3(Hazardous Substances Data)

Established Pharmacologic Class [EPC] - Cytolytic Agent

Physiologic Effects [PE] - Decreased Cell Membrane Integrity

Deoxycholic acid is a Cytolytic Agent. The physiologic effect of deoxycholic acid is by means of Decreased Cell Membrane Integrity.

DEOXYCHOLIC ACID

MeSH Pharmacological ClassificationGastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
Absorption, Distribution and Excretion · 3건

Deoxycholic acid is rapidly absorbed after subcutaneous administration. After maximum recommended single treatment dose, 100mg, the post-treatment plasma levels returned to endogenous levels within 24 hours. With the proposed treatment guideline, no accumulation is expected.

The exogenous deoxycholic acid joins the endogenous bile acid pool in the enterohepatic circulation and is excreted unchanged in feces along with endogenous deoxycholic acid.

LIVER NORMALLY SECRETES APPROX 24 G OF BILE SALTS IN 700 TO 1000 ML OF BILE IN 24 HR. MOST OF BILE SALTS ARE REABSORBED IN LOWER SMALL INTESTINE & AGAIN BECOME AVAILABLE FOR SECRETION. ... POOL OF BILE SALTS IS APPROX 2 TO 5 G. /BILE SALTS/

Tissue LocationsErythrocyte
Cellular LocationsExtracellular
Metabolite Pathways27-Hydroxylase Deficiency

용도 및 제조

Uses · 3건

Naturally occurs in the bile of man, ox, sheep, dog, goat, and rabbit; [Merck Index] Used as emulsifying agent in food, a precursor in the synthesis of cortisone, and a gallbladder stimulant; [HSDB]

EMULSIFYING AGENT IN FOOD; PRECURSOR FOR ORG SYNTHESIS OF CORTISONE

CHOLERETIC

Methods of Manufacturing · 2건

ISOLATION: WIELAND, SIEBERT, Z PHYSIOL CHEM 262, 1 (1939). FROM CHOLIC ACID: SIFFERD, US PATENT 2,765,316 (1956 TO ARMOUR). STRUCTURE & SYNTHESIS: LF LIESER, M FIESER, STEROIDS (REINHOLD, NY, 1959). LAB PREPN FROM OX BILE: GATTERMANN-WIELAND, PRAXIS DES ORGANISCHEN CHEMIKERS (DE GRUYTER, BERLIN, 40TH ED, 1961) PAGE 361.

Isolation from bile.

Formulations/PreparationsGRADES: TECHNICAL; FCC (AS DESOXYCHOLIC ACID)
General Manufacturing Information · 5건

Cholan-24-oic acid, 3,12-dihydroxy-, (3.alpha.,5.beta.,12.alpha.)-: ACTIVE

COMPLEXES WITH FATTY ACIDS HAVE BEEN STUDIED EXTENSIVELY: SOBOTKA, GOLDBERG, BIOCHEM J 26, 555 (1932); SOBOTKA, CHEM REV 15, 362 (1934). SURFACE ACTIVITY: IDEM, CHEMISTRY OF THE STEROIDS, NY (1938).

BILE ACIDS DO NOT OCCUR IN BILE AS SUCH BUT RATHER AS THE SALT FORM CONJUGATED WITH TAURINE OR GLYCINE. /BILE ACIDS/

AN ADDUCT WITH MENTHOL IS MARKETED UNDER NAME DEGALOL.

FORMS MOLECULAR COORDINATION COMPD (SO CALLED CHOLEIC ACIDS) WITH MANY SUBSTANCES;

응용 분야 · 3건

개요Deoxycholic acid sodium salt, which is a secondary bile acid and the metabolite of intestinal bacteria, provides a nonsurgical treatment to significantly reduce submental fat in adults via injection directly into moderate-to-severe fatty tissue below the neck. When injected into fatty tissue, deoxycholic acid helps destroy fat cells. Although deoxycholic acid has many applications beyond human health, the application as a dyslipidemia drug was licensed to Kythera from Los Angeles Biomedical Institute at Harbor-UCLA Medical Center in 2007. Allergan acquired Kythera recently in 2015.

용도Deoxycholic acid has been used in a modified procedure to recover 40-80% of a protein from a 1 μg/mL solution. It forms complexes with fatty acid. Used as an emulsifying agent in food, a precursor in the synthesis of cortisone, and a gallbladder stimulant. It has been used to study assess how physiological concentrations of ursodeoxycholic acid (UDCA) vs. deoxycholic acid (DCA) affect barrier function in mouse intestinal tissue. Deoxycholic acid has been used in a study to assess a pH-Responsive Mechanism of a Deoxycholic Acid and Folate Co-Modified Chitosan Micelle under Cancerous Environment. It has also been used in a study to investigate dose-dependent anti-inflammatory effect of ursodeoxycholic acid in experimental colitis.

일반 설명This [TM="Certified Spiking Solution" is suitable for use as starting material in the preparation of linearity standards, calibrators, and controls in LC-MS/MS and GC/MS bile acid testing methods. Deoxycholic acid (DCA), also known as deoxycholate and cholanoic acid is a secondary bile acid that aids in the absorption of fats in the intestine. Mass spectrometry-based analysis of DCA is routinely performed in clinical diagnostic testing applications including neonatal testing of inborn errors of bile acid synthesis and differentiating among types of familial intrahepatic cholestasis.

상·하류 제품 정보

하류 제품

Taurodeoxycholic acid sodium saltGlycodeoxycholic acid나트륨 데스옥시클로산